204 related articles for article (PubMed ID: 33210843)
1. Cystic fibrosis year in review 2019: Section 3 multisystem-based care and research.
Savant AP; McColley SA
Pediatr Pulmonol; 2023 Mar; 58(3):697-703. PubMed ID: 33210843
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis year in review 2019: Section 1 CFTR modulators.
Savant AP; McColley SA
Pediatr Pulmonol; 2020 Dec; 55(12):3236-3242. PubMed ID: 32833326
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections.
Savant AP; McColley SA
Pediatr Pulmonol; 2023 Mar; 58(3):672-682. PubMed ID: 32970381
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation.
Antos NJ; Savant AP
Pediatr Pulmonol; 2022 Feb; 57(2):347-360. PubMed ID: 34033706
[TBL] [Abstract][Full Text] [Related]
5. The Changing Epidemiology of Cystic Fibrosis: The Implications for Adult Care.
Burgel PR; Burnet E; Regard L; Martin C
Chest; 2023 Jan; 163(1):89-99. PubMed ID: 35850286
[TBL] [Abstract][Full Text] [Related]
6. The future of cystic fibrosis care: a global perspective.
Bell SC; Mall MA; Gutierrez H; Macek M; Madge S; Davies JC; Burgel PR; Tullis E; Castaños C; Castellani C; Byrnes CA; Cathcart F; Chotirmall SH; Cosgriff R; Eichler I; Fajac I; Goss CH; Drevinek P; Farrell PM; Gravelle AM; Havermans T; Mayer-Hamblett N; Kashirskaya N; Kerem E; Mathew JL; McKone EF; Naehrlich L; Nasr SZ; Oates GR; O'Neill C; Pypops U; Raraigh KS; Rowe SM; Southern KW; Sivam S; Stephenson AL; Zampoli M; Ratjen F
Lancet Respir Med; 2020 Jan; 8(1):65-124. PubMed ID: 31570318
[TBL] [Abstract][Full Text] [Related]
7. Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis.
Sathe M; Sharma PB; Savant AP
Pediatr Pulmonol; 2021 Oct; 56(10):3120-3125. PubMed ID: 34310872
[TBL] [Abstract][Full Text] [Related]
8. Advances in the diagnosis and treatment of cystic fibrosis.
Martiniano SL; Hoppe JE; Sagel SD; Zemanick ET
Adv Pediatr; 2014 Aug; 61(1):225-43. PubMed ID: 25037130
[TBL] [Abstract][Full Text] [Related]
9. [Evidence-based treatment of cystic fibrosis].
Ringshausen FC; Hellmuth T; Dittrich AM
Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
[TBL] [Abstract][Full Text] [Related]
10. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.
Karb DB; Cummings LC
Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955
[TBL] [Abstract][Full Text] [Related]
11. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
Konrad J; Eber E; Stadlbauer V
Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator modulators for cystic fibrosis: a new dawn?
Edmondson C; Course CW; Doull I
Arch Dis Child; 2021 Oct; 106(10):941-945. PubMed ID: 33785533
[TBL] [Abstract][Full Text] [Related]
13. Review of CFTR modulators 2020.
Goetz DM; Savant AP
Pediatr Pulmonol; 2021 Dec; 56(12):3595-3606. PubMed ID: 34407318
[TBL] [Abstract][Full Text] [Related]
14. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy in cystic fibrosis: Review of the literature and expert recommendations.
Jain R; Kazmerski TM; Zuckerwise LC; West NE; Montemayor K; Aitken ML; Cheng E; Roe AH; Wilson A; Mann C; Ladores S; Sjoberg J; Poranski M; Taylor-Cousar JL
J Cyst Fibros; 2022 May; 21(3):387-395. PubMed ID: 34456158
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis year in review 2021.
Savant AP
Pediatr Pulmonol; 2022 Jul; 57(7):1590-1599. PubMed ID: 35501666
[TBL] [Abstract][Full Text] [Related]
17. The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis.
Chin M; Aaron SD; Bell SC
Presse Med; 2017 Jun; 46(6 Pt 2):e139-e164. PubMed ID: 28576636
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
Sathe MN; Freeman AJ
Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
[TBL] [Abstract][Full Text] [Related]
19. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
20. Critical Care of the Adult Patient With Cystic Fibrosis.
King CS; Brown AW; Aryal S; Ahmad K; Donaldson S
Chest; 2019 Jan; 155(1):202-214. PubMed ID: 30077689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
